P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)

Saved in:
Bibliographic Details
Main Authors: Maha Tageldein, Derek Wong, Julia Sobotka, Carolina Barnett-Tapia, Hamid Sadeghian, Emily Thain, Katharine Cardiff, Particia Parkin, Raymond Kim, Trevor Pugh
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Genetics in Medicine Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774425009951
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850175784499544064
author Maha Tageldein
Derek Wong
Julia Sobotka
Carolina Barnett-Tapia
Hamid Sadeghian
Emily Thain
Katharine Cardiff
Particia Parkin
Raymond Kim
Trevor Pugh
author_facet Maha Tageldein
Derek Wong
Julia Sobotka
Carolina Barnett-Tapia
Hamid Sadeghian
Emily Thain
Katharine Cardiff
Particia Parkin
Raymond Kim
Trevor Pugh
author_sort Maha Tageldein
collection DOAJ
format Article
id doaj-art-20ebcce7b86f4f948258a00e5cb376c1
institution OA Journals
issn 2949-7744
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Genetics in Medicine Open
spelling doaj-art-20ebcce7b86f4f948258a00e5cb376c12025-08-20T02:19:23ZengElsevierGenetics in Medicine Open2949-77442025-01-01310295610.1016/j.gimo.2025.102956P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)Maha Tageldein0Derek Wong1Julia Sobotka2Carolina Barnett-Tapia3Hamid Sadeghian4Emily Thain5Katharine Cardiff6Particia Parkin7Raymond Kim8Trevor Pugh9University of Toronto, Princess Margaret Cancer CentrePrincess Margaret Cancer CentrePrincess Margaret Cancer CentreUniversity Health NetworkUniversity Health NetworkPrincess Margaret Cancer CentrePrincess Margaret Cancer CentreThe Hospital for Sick ChildrenPrincess Margaret Cancer Centre; Ontario Institute for Cancer ResearchUniversity of Toronto, Princess Margaret Cancer Centre, Ontario Institute for Cancer Researchhttp://www.sciencedirect.com/science/article/pii/S2949774425009951
spellingShingle Maha Tageldein
Derek Wong
Julia Sobotka
Carolina Barnett-Tapia
Hamid Sadeghian
Emily Thain
Katharine Cardiff
Particia Parkin
Raymond Kim
Trevor Pugh
P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)
Genetics in Medicine Open
title P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)
title_full P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)
title_fullStr P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)
title_full_unstemmed P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)
title_short P112: Phenotype prediction using cell-free DNA fragmentation as a predictor of clinical severity in neurofibromatosis type 1 (NF1)
title_sort p112 phenotype prediction using cell free dna fragmentation as a predictor of clinical severity in neurofibromatosis type 1 nf1
url http://www.sciencedirect.com/science/article/pii/S2949774425009951
work_keys_str_mv AT mahatageldein p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT derekwong p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT juliasobotka p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT carolinabarnetttapia p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT hamidsadeghian p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT emilythain p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT katharinecardiff p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT particiaparkin p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT raymondkim p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1
AT trevorpugh p112phenotypepredictionusingcellfreednafragmentationasapredictorofclinicalseverityinneurofibromatosistype1nf1